Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “AstraZeneca”
Sponsor: AstraZeneca
Systemic Lupus Erythematosus · Idiopathic Inflammatory Myopathies · Rheumatoid Arthritis
United States, Canada, China, France, Germany +5 more
Sponsor: Centre Hospitalier Universitaire de Besancon
Hepatocellular Carcinoma
France
Sponsor: AstraZeneca
Non-small Cell Lung Cancer
United States, Belgium, Canada, France, Hungary +7 more
- A Study to Investigate the Relative Bioavailability and Safety of Different Oral Formulations of Elecoglipron in Healthy ParticipantsNot Yet Recruiting
Sponsor: AstraZeneca
Healthy Participants
United States
Sponsor: AstraZeneca
Systemic Lupus Erythematosus
United States, Canada, France, Germany, Italy +4 more
- T-DXd Based Therapy Followed by Endocrine Therapy Plus Dual HER2 Blockade in First-line HER2+/ HR+ Metastatic Breast Cancer and Retreatment With T-DXdNot Yet Recruiting
Sponsor: Daiichi Sankyo
Advanced Breast Cancer · Metastatic Breast Cancer · HER2 Positive · HR Positive
- iCaReMe Global Registry: Multinational Real-world Evidence in Cardiorenal and Metabolic DiseasesRecruiting
Sponsor: AstraZeneca
Type 2 Diabetes · Hypertension · Chronic Kidney Disease · Heart Failure
Brazil, Chile, Costa Rica, Côte d’Ivoire, Egypt +15 more
Sponsor: AstraZeneca
Non-squamous Non-Small Cell Lung Cancer
Brazil
Sponsor: AstraZeneca
Non-small Cell Lung Cancer
Spain
Sponsor: AstraZeneca
Asthma
China
Sponsor: AstraZeneca
CRSwNP or CRSsNP Patients
Greece
Sponsor: AstraZeneca
High-risk Muscle Invasive Urothelial Carcinoma
United States, Australia, Brazil, Canada, China +11 more
- Pooled Analysis of Single-arm Studies of Budesonide/Glycopyrronium/Formoterol (BGF) in Routine Care SettingActive Not Recruiting
Sponsor: AstraZeneca
Pulmonary Disease, Chronic Obstructive
Canada, Germany, Greece, Italy, Japan +2 more
Sponsor: AstraZeneca
Gynaecological Cancers
Brazil
- Impact of GDMT in Uncontrolled Asthma Patients Receiving MHD Inhaled Corticosteroids + Long-acting β2 AgonistNot Yet Recruiting
Sponsor: AstraZeneca
Uncontrolled Asthma
China
- Achievement of LLDAS5 in Patients With Systemic Lupus Erythematosus Treated With Anifrolumab.Recruiting
Sponsor: AstraZeneca
Lupus Erythematosus, Systemic
Italy
- A Prospective, Non-interventional, Observational Study of Presentation, Treatment Patterns and Outcomes in Atypical Hemolytic Uremic Syndrome PatientsActive Not Recruiting
Sponsor: AstraZeneca
Atypical Hemolytic Uremic Syndrome(aHUS)
China
- Danicopan PMS in KoreaRecruiting
Sponsor: AstraZeneca
Paroxysmal Nocturnal Hemoglobinuria
South Korea
- DESTINY-PANTUMOUR04Recruiting
Sponsor: AstraZeneca
Adenocarcinoma (NOS) · Anal Cancer · Bladder Cancer · Cervical Cancer
United States
Sponsor: University of Utah
Non-Small Cell Lung Cancer Metastatic
United States
Sponsor: AstraZeneca
Moderate to Severe COPD
India
Sponsor: Abramson Cancer Center at Penn Medicine
Lung Cancer · Adherence, Patient
United States
Sponsor: AstraZeneca
Metastatic Breast Cancer
Brazil
- The Fontan Dapagliflozin Pilot StudyCompleted
Sponsor: Johns Hopkins University
Heart Failure
United States
Sponsor: AstraZeneca
Neurofibromatosis 1 · Neurofibroma, Plexiform
South Korea